Articles Tagged With:
-
FDA Steps Back from Antibacterial Soap Products
Agency says certain antiseptic washes containing specific chemicals may do more harm than good.
-
Lawsuits Accuse Pharma Companies of Deceiving Docs Over Opioid Risks
Pharmaceutical companies, including OxyContin manufacturer, are being taken to task over what states are calling deceptive marketing of dangerous opioids.
-
Researchers: Zika Treatment May Lie in Existing Drugs
A team of researchers discovered compounds that could help combat Zika -- but don't look for them on the market anytime soon.
-
Hospital CMS CoPs Made Easy
Does your hospital have what it takes to comply with CMS Hospital CoPs? -
FDA: Don’t Mix Benzos, Opioids, and Cough Syrup
Federal agency issues boxed warning in regard to serious risks of mixing potent drugs.
-
Hospital Consult - September 2016
-
Seniors with Higher Continuity of Care Less Likely to Visit ED
In an analysis of those with Medicare, more consistent outpatient care was associated with decreased chances of an ED visit.
-
U.S. Preventive Services Task Force Recommends Against Genital Herpes Screening
The CDC estimates that about one in six U.S. residents ages 14-49 has genital herpes.1 In new draft guidance, the U.S. Preventive Services Task Force (USPSTF) recommends against using current blood tests to screen for genital herpes in people with no signs or symptoms of infection, including adolescents and adults, as well as pregnant women.2
-
The Trajectories of Vasomotor Symptoms Eyed Across the Menopausal Transition
Most women will get hot flashes or night sweats at some point during menopause. Research indicates 42% to 79% of women experience vasomotor symptoms (VMSs) during the menopausal transition.1-4 Just-published findings show that women fit into four distinct groups when it comes to having hot flashes and night sweats, which offers potential ramifications for therapy and prevention of future health conditions, according to research led by the Graduate School of Public Health at the University of Pittsburgh.5
-
Counsel on Convenience and Effectiveness Of Immediate Postpartum LARC
Unplanned pregnancies can happen in the postpartum period. Data indicate 40-57% of women report having unprotected intercourse before the routine six-week postpartum visit.1,2 The American College of Obstetricians and Gynecologists (ACOG) has just issued a new committee opinion on the use of long-acting reversible contraception (LARC) in the postpartum period to help stem such pregnancies.3